Japan Tissue Engineering, The Current Fiscal Year Ordinary Profit Revised Downward to a Loss

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Jan 31, 2025 3:30 pm JST Earnings

7774 Japan Tissue Engineering Co., Ltd. 【J-GAAP】

Earnings Report

Japan Tissue Engineering Co., Ltd. <7774> [TSE Growth] announced its financial results after the market closed on January 31st (15:30). The ordinary loss (non-consolidated) for the cumulative third quarter of the fiscal year ending March 2025 (April to December) expanded to a loss of 330 million yen (compared to a loss of 50 million yen in the same period last year).

In addition, the full-year ordinary profit/loss has been revised downward from an expected profit of 123 million yen to a loss of 202 million yen (compared to a profit of 147 million yen in the previous period), turning to a loss outlook.

Based on the full-year plan announced by the company after the downward revision, our estimate of the ordinary profit for the October to March period (2H) has decreased 98.8%, from the previous forecast of 329 million yen to 4 million yen (compared to 156 million yen in the same period of the previous year). This changes the outlook from an anticipated profit increase to a projection of a 97.4% decrease in profit.

In the most recent three-month period, from October to December (3Q), the ordinary loss expanded to a loss of 124 million yen (compared to a loss of 41 million yen in the same period last year). The operating profit/loss margin drastically worsened from -7.6% in the same period last year to -22.8%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2022	1,443	-624	-622	-625	-15.4	ー	Jan 27, 2023	J-GAAP
Apr - Dec, 2023	1,785	-51	-50	-53	-1.3	ー	Jan 30, 2024	J-GAAP
Apr - Dec, 2024	1,706	-331	-330	-350	-8.6	ー	Jan 31, 2025	J-GAAP
YoY	-4.4%	-549.0%	-560.0%	-560.4%	-553.0%

Guidance Update

Second Half Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2024 Prev	1,783	327	329	312	7.7	0	Oct 31, 2024	J-GAAP
Oct - Mar, 2024 New	1,339	7	4	2	0.1	0	Jan 31, 2025	J-GAAP
Revision Rate	-24.9%	-97.9%	-98.8%	-99.4%	-99.3%

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2025 Prev	2,944	120	123	87	2.1	0	Apr 30, 2024	J-GAAP
Mar, 2025 New	2,500	-200	-202	-223	-5.5	0	Jan 31, 2025	J-GAAP
Revision Rate	-15.1%	－	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	1,268	154	156	154	3.8	0	Apr 30, 2024	J-GAAP
Oct - Mar, 2024 Guidance	1,339	7	4	2	0.1	0	Jan 31, 2025	J-GAAP
YoY	+5.6%	-95.5%	-97.4%	-98.7%	-98.7%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	2,032	-728	-725	-729	-18.0	0	Apr 27, 2023	J-GAAP
Mar, 2024	2,514	144	147	143	3.5	0	Apr 30, 2024	J-GAAP
Mar, 2025 Guidance	2,500	-200	-202	-223	-5.5	0	Jan 31, 2025	J-GAAP
YoY	-0.6%	－	－	－	－

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	539	-41	-41	-42	-1.1	-7.6	Jan 30, 2024	J-GAAP
Jan - Mar, 2024	729	195	197	196	4.8	26.7	Apr 30, 2024	J-GAAP
Apr - Jun, 2024	442	-193	-192	-211	-5.2	-43.7	Jul 30, 2024	J-GAAP
Jul - Sep, 2024	719	-14	-14	-14	-0.4	-1.9	Oct 31, 2024	J-GAAP
Oct - Dec, 2024	545	-124	-124	-125	-3.1	-22.8	Jan 31, 2025	J-GAAP
YoY	+1.1%	-202.4%	-202.4%	-197.6%	-193.3%